self-funded plans can exclude
The unprecedented effectiveness and favorable safety record of tirzepatide have secured its 2022 approval by the United States Food and Drug Administration (FDA) for improving glycemic control in type 2 diabetes (T2D) patients [1]
Staying hydrated is a simple but effective way to support your kidneys
In clinical trials involving semaglutide, the incidence of thyroid cancer in treated patients was less than 1%, and no statistically significant increase compared to placebo was established
Rosen CJ, Ingelfinger JR
Brockmueller, A., Sameri, S., Liskova, A., Zhai, K., Varghese, E., Samuel, S